The Commission's Joint Research Centre (JRC) has launched a call for expression of interest for Lung Cancer experts. With this call the JRC is establishing a Working Group to develop guidelines for lung cancer primary prevention, screening and diagnosis together with requirements for lung cancer services covering the entire care pathway.

They are seeking for clinical, scientific, and technical experts in relevant topic areas , as well as from patients and/or caregivers to be appointed as members of the Working Group.

A Chair and a Vice-Chair will also be appointed as an outcome of this call.

Deadline for applications: 31 August 2025

More information on the Commission`s website

The Global Health EDCTP3 has launched a new call for expressions of interest to renew the membership of its Stakeholders’ Group. 

Following the completion of the two-year mandate of the first established group, Global Health EDCTP3 is inviting both ongoing and new member organisations to express their interest in joining the Stakeholders’ Group.

This group plays a key advisory role in the governance of the organisation, complementing the Scientific Committee and supporting the Governing Board.

Deadline for applications: 05 September 2025, 23:59 (CET).

More information on Global Health EDCTP3 website

On June 02, 2025, the European Commission launches a new strategy to make Europe a global leader in life sciences by 2030. Life sciences – the study of living systems, from cells to ecosystems – are central to our health, environment and economy. They drive innovation in medicine, food and sustainable production, adding nearly €1.5 trillion in value to the EU economy and supporting 29 million jobs across the Union.

The Strategy proposes the following actions:

1. Optimising the research and innovation ecosystem
2. Enabling rapid market access for life science innovations
3. Boosting trust, uptake and use of innovation

Further information and fact sheets can be found on the European Commission website.

On July 16, 2025, the European Commission published its proposals for the next Framework Programme for Research and Innovation, "Horizon Europe" (2028-2034), as well as for a new European Competitiveness Fund (ECF). The Multiannual Financial Framework (MFF), also presented, with a total volume of €2 trillion, allocates €175 billion for Horizon Europe and €409 billion for the ECF.

The European Commission's legislative proposals will be coordinated with the Member States in the Council of the European Union and the European Parliament over the next two years.

Further information and fact sheets can be found on the European Commission website.

The new European partnership OHAMR ("One Health Antimicrobial Resistance") launched on June 1, 2025. It brings together 53 organizations from 30 European and non-European countries and supports research and innovation to address the challenges of antimicrobial resistance. Its predecessor, JPIAMR ("Joint Programming Initiative on Antimicrobial Resistance"), ended on May 31, 2025. OHAMR builds on the extensive work of JPIAMR.

OHAMR's first "Joint Transnational Call" is planned for November 2025. It will focus on providing innovative and cost-effective treatment options.

OHAMR website

The work programme of the Health Cluster with the call topics for 2026-2027 is still in the initial phase of coordination between the European Commission and the Member States. It is expected to be published by the European Commission at the end of December 2025. The Science|Business network has published a draft work programme for the Health Cluster.

Science|Business website

Please consider that these are very preliminary documents that are very likely to change significantly. There is no guarantee that the proposed topics will actually be put out to tender. It is also possible that new topics will be added.